Chronic myeloid leukemia (CML) is a type of cancer that affects the blood and bone marrow, where blood cells are produced. It develops slowly over time and mainly affects a specific group of white blood cells called myeloid cells. In chronic myeloid leukemia, the bone marrow produces too many abnormal white blood cells that do not function properly. These abnormal cells gradually build up in the blood and interfere with the production of healthy blood cells. Understanding what chronic myeloid leukemia is helps people recognize its symptoms, causes, and available treatment options, which are important for early detection and management of the condition.
Understanding chronic myeloid leukemia
Basic definition
Chronic myeloid leukemia is a long-term (chronic) type of leukemia that progresses slowly compared to other forms of blood cancer. It begins in the bone marrow and affects the production of white blood cells. The term myeloid refers to the type of blood cells affected, while leukemia refers to cancer of the blood-forming tissues.
How it develops
CML develops when a genetic change occurs in the bone marrow cells. This change causes the cells to grow uncontrollably and produce large numbers of abnormal white blood cells. Over time, these cells accumulate in the blood and spleen, leading to various health problems.
Causes of chronic myeloid leukemia
The main cause of chronic myeloid leukemia is a genetic mutation in the blood-forming stem cells in the bone marrow. This mutation is not usually inherited but occurs during a person’s lifetime.
The Philadelphia chromosome
One of the key features of CML is the presence of an abnormal chromosome known as the Philadelphia chromosome. This occurs when parts of two chromosomes swap places, creating a new gene called BCR-ABL. This gene produces a protein that signals cells to grow and divide uncontrollably.
Risk factors
Although the exact cause of the genetic change is not always known, certain factors may increase the risk of developing CML
- Exposure to high levels of radiation
- Older age (more common in adults over 50)
- Male gender (slightly higher risk than females)
- No clear family inheritance pattern
Symptoms of chronic myeloid leukemia
CML often develops slowly, and many people may not notice symptoms in the early stages. As the disease progresses, symptoms become more noticeable.
Common symptoms
- Fatigue and weakness
- Unexplained weight loss
- Night sweats
- Fever without infection
- Feeling full after eating small amounts of food
- Pain or discomfort in the left side of the abdomen
These symptoms occur because abnormal white blood cells crowd out healthy cells and affect normal body functions.
Enlarged spleen
One of the most common physical signs of CML is an enlarged spleen, also known as splenomegaly. The spleen becomes enlarged because it works harder to filter the excess abnormal blood cells.
Stages of chronic myeloid leukemia
CML progresses in stages, each with different characteristics and levels of severity.
Chronic phase
The chronic phase is the earliest and most common stage of CML. During this phase, symptoms are mild or not noticeable. Many people are diagnosed at this stage through routine blood tests.
Accelerated phase
In the accelerated phase, the disease begins to progress more quickly. Symptoms become more noticeable, and abnormal cells increase in number. Treatment becomes more challenging at this stage.
Blast crisis phase
The blast crisis is the most advanced stage of CML. It behaves like an aggressive form of leukemia, with a high number of immature blood cells (blasts) in the blood and bone marrow. This stage requires urgent medical treatment.
Diagnosis of chronic myeloid leukemia
Doctors use several tests to diagnose CML and determine its stage. Early diagnosis is important for effective treatment.
Blood tests
A complete blood count (CBC) is often the first test used. It can show an unusually high number of white blood cells, which may indicate leukemia.
Bone marrow test
A bone marrow biopsy involves taking a small sample of bone marrow to examine under a microscope. This helps confirm the presence of abnormal cells.
Genetic testing
Genetic tests are used to detect the Philadelphia chromosome or BCR-ABL gene. This is a key marker for diagnosing CML.
Treatment options for chronic myeloid leukemia
Treatment for CML has improved significantly in recent years, allowing many people to manage the condition as a chronic illness.
Targeted therapy
The most common treatment for CML is targeted therapy using drugs called tyrosine kinase inhibitors (TKIs). These medications specifically target the BCR-ABL protein and help stop the growth of cancer cells.
Chemotherapy
In some cases, chemotherapy may be used to kill rapidly dividing cells. However, it is less commonly used today compared to targeted therapies.
Stem cell transplant
A stem cell or bone marrow transplant may be considered for patients who do not respond to other treatments. This procedure replaces damaged bone marrow with healthy stem cells.
Monitoring and follow-up
Regular monitoring is important to track the effectiveness of treatment. Blood tests are used to check the levels of abnormal cells and adjust treatment if necessary.
Living with chronic myeloid leukemia
Many people with CML can live long and productive lives, especially with early diagnosis and proper treatment. Managing the condition involves both medical care and lifestyle adjustments.
Regular medical care
Ongoing check-ups are essential to ensure that treatment is working and to monitor for any changes in the disease.
Healthy lifestyle
Maintaining a healthy lifestyle can support overall well-being. This includes eating a balanced diet, staying physically active, and getting enough rest.
Emotional support
Living with a chronic illness can be emotionally challenging. Support from family, friends, or support groups can help individuals cope with stress and anxiety.
Complications of chronic myeloid leukemia
If left untreated or not properly managed, CML can lead to serious complications.
Progression of disease
Without treatment, CML can progress from the chronic phase to more advanced and aggressive stages, making it harder to control.
Infections
Because the immune system is affected, individuals with CML may be more prone to infections.
Bleeding problems
Low levels of healthy blood cells can lead to increased risk of bleeding or bruising.
Outlook for chronic myeloid leukemia
The outlook for people with CML has improved greatly due to advances in targeted therapy. Many patients respond well to treatment and can maintain normal daily activities. Early detection and consistent treatment are key factors in improving long-term outcomes.
Conclusion-style insight
Chronic myeloid leukemia is a slow-developing blood cancer that affects the bone marrow and leads to the overproduction of abnormal white blood cells. It is closely linked to the Philadelphia chromosome and the BCR-ABL gene mutation. Although it is a serious condition, modern treatments such as targeted therapy have greatly improved survival rates and quality of life. Understanding what chronic myeloid leukemia is helps with early recognition, timely diagnosis, and effective management, giving patients a better chance of living well with the disease.